China Everbright Assets Management Limited Recognised by Chinese Blue Chip Private Fund Index
Everbright China Focus Fund named a founding component fund of Suntime's Chinese Hedge Fund Index
HONG KONG, Sep 07, 2016 - (ACN Newswire) - The first Chinese blue chip private fund index, Suntime's Chinese Hedge Fund Index, launches: China Everbright Assets Management Limited, secondary market arm of China Everbright Limited ("CEL", stock code: 165.HK) is selected as a founding component management company; Everbright China Focus Fund named a founding component fund.
In recent years, the development of Chinese private funds has been amazing. According to Asset Management Association of China's statistics, as of July 2016, there are 16,467 registered private fund management companies and 36,829 registered funds. However, only select few fund management companies manage over ten billion RMB in assets, hence it can be said that these select few management companies are the true "blue chip" and leaders of Chinese private fund industry.
On August 19th, 2016, China's first ten-billion AUM private fund index, Suntime's Chinese Hedge Fund Index, was launched worldwide in 128 countries by China's leading financial data provider Suntime Information Technology Co., Ltd, in collaboration with internationally renowned financial data provider Thomson Reuter. The index is the first of its kind in China and comprises of the flagship products of China's 20 largest and most representative fund management companies.
China Everbright Assets Management Limited, with over 10.8 billion CNY in assets under management and advisement as of July 31, 2016, is the only Hong Kong-registered Chinese management company to be recognized among these 20 fund management companies. The company currently has products in Asian fixes income, global equity long/short, China equity long-only and Asian quantitative strategies. With its global standard institutional set up and rigorous risk management, China Everbright Assets Managements embodies the current state-of-the-art asset management process of Chinese hedge funds.
Chief Investment Officer of China Everbright Limited, Mr. Ping Yang noted: "China Everbright Assets Management Limited, as the secondary market platform of China Everbright Limited, has experienced significant growth in total size of cross-border assets and asset management capabilities. To be selected as a founding component fund management company of Suntime's Chinese Hedge Fund is a public recognition of our company's cross-border asset management business capabilities."
Everbright China Focus Fund, which is selected into Suntime's Chinese Hedge Fund Index, was established in January 2014 and managed by Keith Wu, Managing Director of China Everbright Assets Management Limited and his team. The Fund carries a long-only absolute return mandate and its investment philosophy is to exploit the high growth in Greater China equity market so as to generate compounded long-term absolute return for its investors. In February this year, the Fund was ranked No. 1 in performance among Emerging Market - Asia fund by well-known hedge fund research institution BarclayHedge for its performance in 2015 where the Fund return 46.99%, net of fees, in a single calendar year. In May, the Fund was again recognized by the investment community and received the title of "Best Asian Long Only Absolute Return Fund" from EurekaHedge.
About China Everbright Limited
China Everbright Limited ("CEL", stock code: 165.HK), established in Hong Kong in 1997, persistently pursues its "Macro Asset Management" strategy with specific focuses on cross-border asset management and investment businesses. CEL manages a portfolio of private equity funds, venture capital funds, sector focus funds, mezzanine funds, hedge funds and principal investment funds, all operated via an international management platform, and provides overseas investors with opportunities to explore and invest in companies with fast growth potential in mainland China. CEL also seeks investment opportunities from overseas and provides diversified financial services for its clients on the mainland. China Everbright Limited, a member of China Everbright Group, is the second-largest shareholder of Everbright Securities (stock code: 601788.SH, 6178.HK), a strategic shareholder of China Everbright Bank (stock code: 601818.SH, 6818.HK), the single largest shareholder of the Hong Kong-listed China Aircraft Leasing Group Holdings Limited (stock code: 1848.HK), the largest shareholder of Shanghai Jiabao Industry & Commerce (Group) Co., Ltd (stock code: 600622.SH) and the second-largest shareholder of the Singapore-listed Ying Li International Real Estate Limited (stock code: 5DM.SGX).
After the launch of "Shanghai-Hong Kong Stock Connect" on 10 April 2014, CEL became one of the first batch of specific stocks listed on The Stock Exchange of Hong Kong that can be directly traded by Mainland investors.
By practising its philosophy of "Making Wealth Simple", CEL leverages its own substantial financial strength as well as the position and influence of China Everbright Group and its affiliated companies in the financial industry in China. As a result, the Group has successfully built huge cross-border social and business networks in Hong Kong and the Mainland, and established a reputable image in the market. For more information about CEL, please visit www.everbright165.com.
For enquiries, please contact:
Golin Jackie Cheung Tel: +852 2501 7901 Email: jcheung@golin.com
Max Lau Tel: +852 2501 7905 Email: mlau@golin.com
Source: China Everbright Ltd Sectors: Daily Finance, Funds & Equities
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Hong Kong Watch & Clock Fair, Salon de TIME return in September Aug 30, 2025 02:50 JST
|  Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building Aug 29, 2025 18:54 JST
|  Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma Aug 29, 2025 18:17 JST
|  Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage Aug 29, 2025 15:17 JST
|  SenseTime Announces 2025 Interim Results Aug 28, 2025 21:20 JST
|  Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth Aug 28, 2025 19:09 JST
|  Baguio Green Group (1397.HK) Announces 2025 Interim Results Aug 28, 2025 19:03 JST
|  Production, Sales and Export Results for July, 2025 Aug 28, 2025 17:36 JST
|  Sales, Production, and Export Results for July 2025 Aug 28, 2025 17:25 JST
|  The University of Tokyo and DENSO Jointly Establish a Social Cooperation Program: "Building Sustainable Production System Infrastructure with Advanced AI Technology" Aug 28, 2025 16:33 JST
|  Overview of Honda Exhibits at the Japan Mobility Show 2025 Aug 28, 2025 15:49 JST
|  NEC develops AI technology for digitalizing work tasks without the need for pre-training and utilizing video from multiple cameras covering wide area worksites Aug 27, 2025 22:57 JST
|  Result of the Business Plan Review for the Offshore Wind Power Generation Projects in Japan Aug 27, 2025 22:27 JST
|  Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision Aug 27, 2025 21:50 JST
|  MHI Becomes First Japanese Company to Acquire ISO 19443:2018 Certification in the Nuclear Energy Field Aug 27, 2025 21:32 JST
|  Mitsubishi Logisnext to Demonstrate Automated Forklift Equipped with "SynfoX" at "4th INNOVATION EXPO" Aug 27, 2025 20:59 JST
|  TANAKA to Showcase Advanced Semiconductor Materials in its Inaugural Participation at SEMICON India 2025 Aug 26, 2025 13:30 JST
|  Honda to Hold Official e-Motorsports Event, "Honda Racing eMS 2025" Aug 26, 2025 13:17 JST
|  Mitsubishi Corporation Invests in Fullerton Health Aug 26, 2025 12:54 JST
|  Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab) Aug 25, 2025 19:30 JST
|
More Latest Release >>
|